BACKGROUND: Symptomatic @entity1 with chronic @entity5327 (CMI) should be treated without much delay because symptoms of CMI are present in 43   % @entity1 who present with acute @entity5327 . There are few reported series with large numbers of @entity1 undergoing surgery for CMI, and many controversies persist regarding the optimal surgical treatment. These controversies include the type of surgical repair (antegrade vs. retrograde bypass), and the number of arteries that should be treated (single- vs. multiple-vessel reconstruction). It was the aim of presented study to report our experience and long-term results with single-vessel bypass grafting from infrarenal aorta to superior mesenteric artery. METHODS: @entity1 who were admitted because of @entity5327 at the surgical clinics of University Clinical Center Maribor between January 1999 and January 2009 were identified with a computerized medical data registry. @entity1 who underwent revascularization for CMI with retrograde synthetic aortomesenteric bypass were included in the study. Demographics, clinical characteristics, imaging, and operative data were obtained from the medical records. Significant superior @entity2791 (>   70   % diameter stenosis) was confirmed by spiral computed angiography. All @entity1 underwent retrograde aortomesenteric arterial bypass with synthetic bypass graft originating from the infrarenal aorta. Doppler sonography combined with color Doppler was used to evaluate disease progression in @entity1 at 3-month interval during the first year and from then at 6-month intervals. Endpoints of the study were occlusion of graft or @entity204 by any cause. RESULTS: Data are presented for a cohort of 19 @entity1 and 8 @entity1 with a mean age at admission 73 years (range 56-88 years). The mean duration of follow-up was 71 months (range 1-118 months). There was one early @entity204 (4   %). Four @entity1 died during the follow-up period, and three were lost for follow-up. None of the deaths was connected with @entity5327 . During follow-up period none of the @entity1 developed @entity256 , and no occlusions were observed. There were no reinterventions. Symptom improvements were noted in 25 @entity1 (93   %). One @entity1 (4   %) referred to persistent @entity158 despite successful revascularization, although during follow-up period weight gain was observed. At 71 months, freedom from recurrent symptoms, @entity256 , and reinterventions was 78   %      13.9   %. CONCLUSIONS: Surgery for CMI can be safely performed with retrograde approach and single vessel @entity254 . Mortality rates and long-term survival compare favorably with other surgical approaches to treatment of CMI.

Revascularization of the superior mesenteric artery alone for treatment of chronic XXXX .

@entity1 :: ('9606', 'Species') :: ['men', 'women', 'Patients', 'patients', 'patient'] @entity254 :: ('MESH:C563598', 'Disease') :: ['anastomosis'] @entity256 :: ('MESH:D023903', 'Disease') :: ['restenosis'] @entity2791 :: ('MESH:D012078', 'Disease') :: ['mesenteric artery stenosis'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity5327 :: ('MESH:D065666', 'Disease') :: ['mesenteric ischemia']
@entity5327 :: (MESH:D065666,Disease) :: ['mesenteric ischemia']
